2019 Q4 Form 10-K Financial Statement

#000101008620000006 Filed on March 05, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q2
Revenue $4.264M $8.111M $3.908M
YoY Change 171.77% -98.28% 46.86%
Cost Of Revenue $130.0K $737.0K $0.00
YoY Change 26.21% -99.23%
Gross Profit $4.134M $7.374M $3.908M
YoY Change 181.99% -98.04% 46.86%
Gross Profit Margin 96.95% 90.91% 100.0%
Selling, General & Admin $3.497M $3.196M $3.392M
YoY Change -8.65% 2.61% 17.79%
% of Gross Profit 84.59% 43.35% 86.8%
Research & Development $3.924M $3.344M $2.038M
YoY Change 31.99% -10.19% -38.46%
% of Gross Profit 94.92% 45.34% 52.16%
Depreciation & Amortization $130.0K $130.3K $127.6K
YoY Change 550.0% 785.46% 2982.05%
% of Gross Profit 3.14% 1.77% 3.26%
Operating Expenses $7.421M $7.451M $5.613M
YoY Change 9.12% -92.71% -11.9%
Operating Profit -$3.470M $660.6K -$1.705M
YoY Change -37.38% -99.82% -54.04%
Interest Expense -$3.600M $3.972M $3.971M
YoY Change -35.71% 1.22% 3.33%
% of Operating Profit 601.28%
Other Income/Expense, Net $600.0K $759.9K $737.6K
YoY Change -99.24% 14896.66% 411.67%
Pretax Income -$6.500M -$1.570M -$4.282M
YoY Change -109.62% -100.43% -39.25%
Income Tax -$2.000M -$400.0K -$1.100M
% Of Pretax Income
Net Earnings -$4.503M -$1.206M -$3.162M
YoY Change -108.59% -100.31% -55.15%
Net Earnings / Revenue -105.61% -14.87% -80.92%
Basic Earnings Per Share -$0.06 -$0.01 -$0.04
Diluted Earnings Per Share -$0.06 -$0.03 -$0.05
COMMON SHARES
Basic Shares Outstanding 80.94M shares 81.06M 80.99M
Diluted Shares Outstanding 82.18M 82.11M

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.20M $78.10M $100.3M
YoY Change -35.25% -24.9% 846.23%
Cash & Equivalents $65.25M $78.10M $100.3M
Short-Term Investments
Other Short-Term Assets $100.9M $13.40M $14.70M
YoY Change 538.61% 157.69% -86.24%
Inventory $9.653M $3.931M $2.390M
Prepaid Expenses
Receivables $4.168M $3.218M $4.128M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $180.0M $98.62M $121.5M
YoY Change 48.44% -13.23% -0.69%
LONG-TERM ASSETS
Property, Plant & Equipment $2.618M $2.750M $2.860M
YoY Change 1428.72% 2232.99% 2057.18%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $856.8K $863.0K $930.0K
YoY Change -19.09% -21.2% 17.73%
Total Long-Term Assets $18.52M $104.4M $81.56M
YoY Change -77.45% 247.23% 1267.4%
TOTAL ASSETS
Total Short-Term Assets $180.0M $98.62M $121.5M
Total Long-Term Assets $18.52M $104.4M $81.56M
Total Assets $198.6M $203.0M $203.1M
YoY Change -2.4% 41.25% 58.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.054M $2.252M $1.071M
YoY Change 80.87% 151.66% -24.19%
Accrued Expenses $8.637M $9.544M $10.05M
YoY Change -10.49% 121.39% 205.69%
Deferred Revenue $2.298M
YoY Change
Short-Term Debt $80.04M $0.00 $0.00
YoY Change
Long-Term Debt Due $80.00M
YoY Change
Total Short-Term Liabilities $91.74M $11.80M $11.12M
YoY Change 709.14% 126.59% -97.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $78.90M $77.80M
YoY Change -100.0% 6.05% 6.14%
Other Long-Term Liabilities $9.000M $9.400M $10.70M
YoY Change -33.82% -18.97% -29.14%
Total Long-Term Liabilities $9.000M $88.30M $88.50M
YoY Change -89.9% 2.67% 0.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $91.74M $11.80M $11.12M
Total Long-Term Liabilities $9.000M $88.30M $88.50M
Total Liabilities $100.8M $100.1M $99.64M
YoY Change 0.25% 9.74% -78.79%
SHAREHOLDERS EQUITY
Retained Earnings -$123.0M -$118.5M -$117.3M
YoY Change 6.25% -29.52% -78.91%
Common Stock $220.8M $221.4M $220.8M
YoY Change 0.96% 0.34% 2.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.78M $102.9M $103.5M
YoY Change
Total Liabilities & Shareholders Equity $198.6M $203.0M $203.1M
YoY Change -2.4% 41.25% 58.24%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.503M -$1.206M -$3.162M
YoY Change -108.59% -100.31% -55.15%
Depreciation, Depletion And Amortization $130.0K $130.3K $127.6K
YoY Change 550.0% 785.46% 2982.05%
Cash From Operating Activities -$14.26M $400.0K -$4.350M
YoY Change 297.21% -99.54% -16.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$20.00K $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -980.0K -140.0K 0.000
YoY Change -58.3% -90.34% -100.0%
NET CHANGE
Cash From Operating Activities -14.26M 400.0K -4.350M
Cash From Investing Activities 0.000 -20.00K 0.000
Cash From Financing Activities -980.0K -140.0K 0.000
Net Change In Cash -15.24M 240.0K -4.350M
YoY Change -121.07% -99.72% -16.83%
FREE CASH FLOW
Cash From Operating Activities -$14.26M $400.0K -$4.350M
Capital Expenditures $0.00 -$20.00K $0.00
Free Cash Flow -$14.26M $420.0K -$4.350M
YoY Change 305.11% -99.51% -15.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81272518 shares
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
321463623 USD
CY2019 dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018Q4 siga Accrued Researchand Development Vendor Costs Current
AccruedResearchandDevelopmentVendorCostsCurrent
1446410 USD
CY2019Q4 siga Accrued Researchand Development Vendor Costs Current
AccruedResearchandDevelopmentVendorCostsCurrent
707685 USD
CY2019Q4 siga Amount Received From Contractfor Developmentand Support Activities
AmountReceivedFromContractforDevelopmentandSupportActivities
44900000 USD
CY2018 siga Cash Consideration Received
CashConsiderationReceived
375600000 USD
CY2018Q4 siga Computer Equipment
ComputerEquipment
618248 USD
CY2019Q4 siga Computer Equipment
ComputerEquipment
601797 USD
CY2011Q2 siga Contract Value Detail Of Option Exercisable Development Activities
ContractValueDetailOfOptionExercisableDevelopmentActivities
58300000 USD
CY2011Q2 siga Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
14400000 USD
CY2018Q3 siga Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
525000000 USD
CY2018Q3 siga Contract Value Of Development And Support Activities
ContractValueOfDevelopmentAndSupportActivities
32000000 USD
CY2019 siga Contract Value Option Fda Approval
ContractValueOptionFDAApproval
50000000 USD
CY2011Q2 siga Contract Valueof Various Options
ContractValueofVariousOptions
72700000 USD
CY2017 siga Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
0 USD
CY2018 siga Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
6007847 USD
CY2019 siga Conversionof Warrantsto Common Stock
ConversionofWarrantstoCommonStock
1172801 USD
CY2017 siga Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
-4738753 USD
CY2018 siga Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
-6922624 USD
CY2019 siga Decrease In Fair Value Of Warrants
DecreaseInFairValueOfWarrants
5091256 USD
CY2018Q4 siga Deferred Tax Asset Interest Expense
DeferredTaxAssetInterestExpense
0 USD
CY2019Q4 siga Deferred Tax Asset Interest Expense
DeferredTaxAssetInterestExpense
2617951 USD
CY2018Q4 siga Deferred Tax Asset Lease Liability
DeferredTaxAssetLeaseLiability
0 USD
CY2019Q4 siga Deferred Tax Asset Lease Liability
DeferredTaxAssetLeaseLiability
678993 USD
CY2017 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
-0.043
CY2018 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.004
CY2019 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.105
CY2017 siga Gainon Saleof Prv
GainonSaleofPRV
0 USD
CY2018 siga Gainon Saleof Prv
GainonSaleofPRV
78338826 USD
CY2019 siga Gainon Saleof Prv
GainonSaleofPRV
0 USD
CY2018Q3 siga Government Contract Base Valueof Award For Deliveryof Courses
GovernmentContractBaseValueofAwardForDeliveryofCourses
11100000 USD
CY2011Q2 siga Government Contract Number Of Courses Purchased Under Modified Contract
GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract
1700000 contract
CY2011Q2 siga Government Contract Numberof Additional Courses Purchased Under Modified Contract
GovernmentContractNumberofAdditionalCoursesPurchasedUnderModifiedContract
300000 course
CY2019 siga Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance
GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance
3200000 USD
CY2019 siga Government Contract Paymentsfor Other Base Period Activities
GovernmentContractPaymentsforOtherBasePeriodActivities
4700000 USD
CY2018Q3 siga Government Contract Paymentsfor Supportive Procurement Activities
GovernmentContractPaymentsforSupportiveProcurementActivities
600000 USD
CY2011Q2 siga Government Contract Value Of Award1
GovernmentContractValueOfAward1
508400000 USD
CY2018Q3 siga Government Contract Value Of Award1
GovernmentContractValueOfAward1
602500000 USD
CY2018Q3 siga Governmentcontractbasevalueawardfordeliveryandsupportactivities
Governmentcontractbasevalueawardfordeliveryandsupportactivities
51700000 USD
CY2017 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
325000 USD
CY2018 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
251961 USD
CY2019 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
-1276129 USD
CY2019Q1 siga Increase Decreasein Deferred Rent
IncreaseDecreaseinDeferredRent
400000 USD
CY2017 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
4738753 USD
CY2018 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
6922624 USD
CY2019 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-5091256 USD
CY2017 siga Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
0 USD
CY2018 siga Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
78338826 USD
CY2019 siga Net Proceedsfrom Saleof Priority Review Voucher
NetProceedsfromSaleofPriorityReviewVoucher
0 USD
CY2017 siga Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
0 USD
CY2018 siga Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
281950853 USD
CY2019 siga Net Realizationof Deferred Revenueand Costs Dueto Fda Approval
NetRealizationofDeferredRevenueandCostsDuetoFDAApproval
0 USD
CY2018Q3 siga Number Of Courses To Be Delivered1
NumberOfCoursesToBeDelivered1
1488000 course
CY2018Q3 siga Numberof Courses Delivered Options Final Drug Product
NumberofCoursesDeliveredOptionsFinalDrugProduct
35700 course
CY2019Q2 siga Numberof Courses Dividedinto Procurement Related Options
NumberofCoursesDividedintoProcurementRelatedOptions
363070 course
CY2019 siga Numberof Courses Ivfdp
NumberofCoursesIVFDP
20000 course
CY2018Q3 siga Numberof Courses Options Final Drug Product
NumberofCoursesOptionsFinalDrugProduct
20000 course
CY2019 siga Numberof Courses Options Final Drug Product
NumberofCoursesOptionsFinalDrugProduct
64000 course
CY2018Q3 siga Numberof Courses Storedas Vendor Managed Inventory
NumberofCoursesStoredasVendorManagedInventory
212000 course
CY2018Q3 siga Numberof Primary Manufacturing Steps
NumberofPrimaryManufacturingSteps
2 step
CY2018Q3 siga Numberofcoursesbasefinaldrugproduct
Numberofcoursesbasefinaldrugproduct
8000000 USD
CY2017 siga Patent Preparation Fees
PatentPreparationFees
909946 USD
CY2018Q1 siga Patent Preparation Fees
PatentPreparationFees
218000 USD
CY2018Q2 siga Patent Preparation Fees
PatentPreparationFees
178000 USD
CY2018Q3 siga Patent Preparation Fees
PatentPreparationFees
186000 USD
CY2018Q4 siga Patent Preparation Fees
PatentPreparationFees
207000 USD
CY2018 siga Patent Preparation Fees
PatentPreparationFees
789489 USD
CY2019Q1 siga Patent Preparation Fees
PatentPreparationFees
188000 USD
CY2019Q2 siga Patent Preparation Fees
PatentPreparationFees
182000 USD
CY2019Q3 siga Patent Preparation Fees
PatentPreparationFees
174000 USD
CY2019Q4 siga Patent Preparation Fees
PatentPreparationFees
182000 USD
CY2019 siga Patent Preparation Fees
PatentPreparationFees
726105 USD
CY2019Q2 siga Paymentfor Procurementof Raw Materials
PaymentforProcurementofRawMaterials
11200000 USD
CY2019 siga Paymentsfor Funding Post Marketing Activities
PaymentsforFundingPostMarketingActivities
25800000 USD
CY2019Q4 siga Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts
ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts
459800000 USD
CY2019Q2 siga Proceedsfor Deliveryof Courses
ProceedsforDeliveryofCourses
33800000 USD
CY2018Q4 siga Proceedsfrom Saleof Priority Review Voucher
ProceedsfromSaleofPriorityReviewVoucher
80000000 USD
CY2019 siga Proceedsfrom Saleof Priority Review Voucher
ProceedsfromSaleofPriorityReviewVoucher
78300000 USD
CY2018Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
294794 USD
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
256402 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3244861 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3726313 USD
CY2019Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2019Q4 siga Researchand Development Future Aggregate Amount
ResearchandDevelopmentFutureAggregateAmount
3100000 USD
CY2018Q3 siga Revenue Government Contract
RevenueGovernmentContract
90900000 USD
CY2017 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
4497271 USD
CY2018 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
4497273 USD
CY2019 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
4497271 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1688488 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3054032 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1959133 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4167996 USD
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2600839 USD
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2966139 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9648917 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8636911 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
242043 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
288707 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
218697872 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220808037 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1101031 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2273177 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2113994 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000 USD
CY2018Q4 us-gaap Assets
Assets
203443741 USD
CY2019Q4 us-gaap Assets
Assets
198566190 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
121289845 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
180041785 USD
CY2019Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
620000000 shares
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28701824 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19857833 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100652809 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65249072 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56174046 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37101586 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180396910 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160986934 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19072460 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
143295324 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19409976 USD
CY2016Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.29
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80763350 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81269868 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80763350 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81269868 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
8076 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8127 USD
CY2019 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract
3300000 USD
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
95166000 USD
CY2018Q4 us-gaap Cost Of Revenue
CostOfRevenue
103000 USD
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
95268974 USD
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
915000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
737000 USD
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
130000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
1782838 USD
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-223313 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
623060 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1326022 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-663114 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
624239 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-866850 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-519659 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1179 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
459172 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
143455 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2724371 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-9256661 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2092585 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2718029 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9301422 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2417617 USD
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4159946 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2298341 USD
CY2019 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1000000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
6342 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-44761 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-325032 USD
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
1326228 USD
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
719304 USD
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
171044 USD
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
113910 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13264102 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15936739 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11733385 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
14151002 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
11733385 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
14151002 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12212795 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
14889731 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9798319 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9353603 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1028083 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1338046 USD
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
371804 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
663114 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
60535 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
508089 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
451818 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1051307 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1047008 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
192146 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
201930 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
287264 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
361218 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
175581 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132189 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69630 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
526997 USD
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.85
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.28
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.71
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.18
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.055
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.025
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.289
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.360
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.247
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.051
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
-0.060
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.018
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.021
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.039
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6116882 USD
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
377859 USD
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
377859 USD
CY2017 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1225421 USD
CY2018 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2019Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38329274 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
411639556 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10178423 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2093790 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10168272 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2937276 USD
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2051081 USD
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2045191 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
936839 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1352263 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
49723 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2208863 USD
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
23943057 USD
CY2018 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
CY2019 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11412898 USD
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3475714 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1861605 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22690715 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6744644 USD
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1125657 USD
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2579329 USD
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
714272 USD
CY2017 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2018 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
2785177 shares
CY2019 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1143769 shares
CY2017 us-gaap Interest Expense
InterestExpense
14758140 USD
CY2018 us-gaap Interest Expense
InterestExpense
15478203 USD
CY2019 us-gaap Interest Expense
InterestExpense
15769768 USD
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
35567 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
977724 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
957765 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
959398 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
2908210 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
9652855 USD
CY2018Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1950445 USD
CY2019Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
8693457 USD
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
536000 USD
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2420028 USD
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2420028 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3300386 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
982881 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
542340 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
404258 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
402078 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
368467 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
600362 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
482097 USD
CY2018Q4 us-gaap Liabilities
Liabilities
100529054 USD
CY2019Q4 us-gaap Liabilities
Liabilities
100782434 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
203443741 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
198566190 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11337405 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91735809 USD
CY2018Q4 us-gaap Loans Payable
LoansPayable
75547597 USD
CY2019Q4 us-gaap Loans Payable
LoansPayable
0 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-585569 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3812561 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1176579 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100124 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78236562 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29094 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18386767 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68871323 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18204303 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-36235484 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-11582000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-7051000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
388050000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
52391000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
421807828 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1630000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3162000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1206000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-4503000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7241147 USD
CY2017 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-36235484 USD
CY2018 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
428730452 USD
CY2019 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-12332403 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16788 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
78940985 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2822232 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
31118129 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
121954384 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
29064228 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-18849169 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4535000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3710000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
368885000 USD
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5541000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
355099398 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2192000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1705000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
661000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
600000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2818289 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3300000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3470000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2322143 USD
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
700000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
419709 USD
CY2018 us-gaap Operating Lease Payments
OperatingLeasePayments
600000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2900000 USD
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0453
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M6D
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3019928 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
541376 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
352000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
320774 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
304000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
304000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1197778 USD
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
38200000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
869318 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
722204 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1058880 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
856766 USD
CY2018Q4 us-gaap Other Liabilities
OtherLiabilities
1263113 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
2929743 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
84000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
591067 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4074440 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1176579 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100124 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102264 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29094 USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4317615 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5234000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
89498 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
261879 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1172801 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3416135 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6344616 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
171274 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2618303 USD
CY2019Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
26800000 USD
CY2019Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
50000 USD
CY2018Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
200000 USD
CY2019 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
200000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16679712 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3008000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3312000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3723000 USD
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2973000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13016183 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3997000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2038000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3344000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3924000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13303149 USD
CY2016Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
10138890 USD
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
10701305 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11452078 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
95737862 USD
CY2016Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
17333332 USD
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6542448 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
68292023 USD
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115791261 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123032408 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
200000 USD
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12268960 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
477053782 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26742085 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30000000 USD
CY2018Q1 us-gaap Revenues
Revenues
1748000 USD
CY2018Q2 us-gaap Revenues
Revenues
2661000 USD
CY2018Q3 us-gaap Revenues
Revenues
471075000 USD
CY2018Q4 us-gaap Revenues
Revenues
1569000 USD
CY2019Q1 us-gaap Revenues
Revenues
10459000 USD
CY2019Q2 us-gaap Revenues
Revenues
3908000 USD
CY2019Q3 us-gaap Revenues
Revenues
8111000 USD
CY2019Q4 us-gaap Revenues
Revenues
4264000 USD
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12303050 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3115000 USD
CY2018Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3828000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12879738 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3057000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2880000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3167000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3392000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3196000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3497000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13252136 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1101031 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2273177 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2113994 USD
CY2010Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4500000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8500000 shares
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80044866 USD
CY2018 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
6007847 USD
CY2019 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
1172801 USD
CY2017 us-gaap Stock Issued1
StockIssued1
0 USD
CY2018 us-gaap Stock Issued1
StockIssued1
1681426 USD
CY2019 us-gaap Stock Issued1
StockIssued1
118500 USD
CY2017 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
84000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-287418269 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-323138291 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
102914687 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97783756 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5738964 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5649188 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
89776 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5738964 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5600000 USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
101500000 USD
CY2018Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
12380939 USD
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6116882 USD
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78874494 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82708472 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82175023 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78874494 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79923295 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81031254 shares
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceeds the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes the potential for losses is remote. </font></div></div>
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. The most significant estimates include the variables used in the calculation of fair value of warrants granted or issued by the Company, reported amounts of revenue, and the valuation of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001010086-20-000006-index-headers.html Edgar Link pending
0001010086-20-000006-index.html Edgar Link pending
0001010086-20-000006.txt Edgar Link pending
0001010086-20-000006-xbrl.zip Edgar Link pending
a4b-description_ofxsecurit.htm Edgar Link pending
amdofsolmodofcontractform1.htm Edgar Link pending
amdofsolmodofcontractform2.htm Edgar Link pending
chart-930878859a9456cd961.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20191231.xml Edgar Link completed
siga-20191231.xsd Edgar Link pending
siga-20191231x10k.htm Edgar Link pending
siga-20191231_cal.xml Edgar Link unprocessable
siga-20191231_def.xml Edgar Link unprocessable
siga-20191231_lab.xml Edgar Link unprocessable
siga-20191231_pre.xml Edgar Link unprocessable
siga-exhibit2312019ye1.htm Edgar Link pending
siga-exhibit3112019ye1.htm Edgar Link pending
siga-exhibit3122019ye1.htm Edgar Link pending
siga-exhibit3212019ye1.htm Edgar Link pending
siga-exhibit3222019ye1.htm Edgar Link pending